PapersFlow Research Brief
Urticaria and Related Conditions
Research Guide
What is Urticaria and Related Conditions?
Urticaria and related conditions refer to a cluster of disorders characterized by itchy wheals or hives, focusing on chronic spontaneous urticaria, its diagnosis, classification, management, autoimmune mechanisms, treatments such as omalizumab, quality of life impacts, and associations with thyroid autoimmunity and autoantibodies.
This field encompasses 64,745 papers on urticaria, particularly chronic spontaneous urticaria, with emphasis on diagnosis, autoimmune factors, and management strategies. Key areas include the role of mast cells in urticaria pathogenesis, as mast cells reside in tissues near blood vessels, nerves, and environmental interfaces, depending on stem cell factor for development (Metcalfe et al. (1997) in "Mast cells"). Treatments like omalizumab target IgE-mediated processes involving mast cells, basophils, and eosinophils (Stone et al. (2010) in "IgE, mast cells, basophils, and eosinophils").
Topic Hierarchy
Research Sub-Topics
Chronic Spontaneous Urticaria Pathophysiology
This sub-topic elucidates mast cell activation mechanisms, basophil histamine release, and cytokine profiles in CSU. Researchers investigate intrinsic vs. extrinsic triggers using omics approaches.
Omalizumab Treatment in Chronic Urticaria
Clinical trials and real-world studies evaluate omalizumab's efficacy, dosing, and predictors of response in refractory CSU. Research explores IgE-independent effects and long-term relapse rates.
Autoantibodies in Urticaria Diagnosis
Focuses on anti-FcεRI and anti-IgE autoantibodies as biomarkers for autoimmune CSU subsets. Assay standardization and prognostic utility are key research areas.
Thyroid Autoimmunity in Chronic Urticaria
Epidemiological and mechanistic studies link Hashimoto's thyroiditis to CSU via shared autoimmune pathways. Interventions test antithyroid therapy's impact on urticaria remission.
Quality of Life in Urticaria Patients
Develops and validates Urticaria Activity Score (UAS) and Dermatology Life Quality Index (DLQI) for longitudinal assessment. Research quantifies psychosocial burden and treatment benefits.
Why It Matters
Urticaria and related conditions affect patient quality of life through persistent itching and wheals, with management relying on antihistamines and biologics like omalizumab for chronic spontaneous urticaria. Autoantibodies serve as diagnostic markers, similar to their use in other autoimmune diseases, enabling targeted therapy (van der Woude et al. (1985) in "AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS"). Mast cell involvement underscores treatments addressing degranulation in autoimmune urticaria, impacting rheumatology practice by linking urticaria to thyroid autoimmunity. For instance, omalizumab reduces symptoms in refractory cases, improving daily functioning as noted in management studies within this cluster.
Reading Guide
Where to Start
"Mast cells" by Metcalfe et al. (1997), as it provides foundational understanding of mast cell biology central to urticaria mechanisms, with 1701 citations.
Key Papers Explained
"Mast cells" (Metcalfe et al. (1997)) establishes mast cell tissue distribution and stem cell factor dependence, which "IgE, mast cells, basophils, and eosinophils" (Stone et al. (2010)) builds upon by detailing IgE-mediated activation relevant to omalizumab therapy. "AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS" (van der Woude et al. (1985)) extends autoantibody diagnostics to urticaria-thyroid links. "Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome" (Hoffman et al. (2001)) connects autoinflammatory genetics to urticaria-related syndromes.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current focus remains on omalizumab optimization and autoantibody markers for chronic spontaneous urticaria, with no recent preprints or news available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Diagnostic Features of Atopic Dermatitis | 1980 | Acta Dermato Venereolo... | 5.1K | ✓ |
| 2 | Atopic Dermatitis | 2000 | — | 4.6K | ✕ |
| 3 | The Definition and Classification of Dry Eye Disease: Report o... | 2007 | The Ocular Surface | 3.2K | ✕ |
| 4 | Pharmacotherapy: A Pathophysiologic Approach | 1989 | Annals of Internal Med... | 2.4K | ✕ |
| 5 | AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIA... | 1985 | The Lancet | 1.9K | ✕ |
| 6 | HLA-B*5701 Screening for Hypersensitivity to Abacavir | 2008 | New England Journal of... | 1.8K | ✓ |
| 7 | Mast cells | 1997 | Physiological Reviews | 1.7K | ✕ |
| 8 | Mutation of a new gene encoding a putative pyrin-like protein ... | 2001 | Nature Genetics | 1.6K | ✓ |
| 9 | IgE, mast cells, basophils, and eosinophils | 2010 | Journal of Allergy and... | 1.6K | ✓ |
| 10 | 2012 American College of Rheumatology guidelines for managemen... | 2012 | Arthritis Care & Research | 1.5K | ✓ |
Frequently Asked Questions
What role do mast cells play in urticaria?
Mast cells reside in tissues throughout the body, particularly near blood vessels, nerves, and environmental interfaces. They are bone marrow-derived and depend on stem cell factor for development (Metcalfe et al. (1997) in "Mast cells"). In urticaria, mast cell degranulation triggers wheal formation.
How are autoantibodies used in urticaria diagnosis?
Autoantibodies against neutrophils and monocytes act as tools for diagnosis and markers of disease activity in autoimmune conditions associated with urticaria. This approach mirrors their application in Wegener's granulomatosis (van der Woude et al. (1985) in "AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS"). In urticaria, they link to thyroid autoimmunity for improved classification.
What is the involvement of IgE in urticaria management?
IgE interacts with mast cells, basophils, and eosinophils to mediate allergic responses in urticaria. Omalizumab targets IgE to control chronic spontaneous urticaria (Stone et al. (2010) in "IgE, mast cells, basophils, and eosinophils"). This reduces wheal and itch severity.
How does thyroid autoimmunity relate to urticaria?
Thyroid autoimmunity associates with chronic spontaneous urticaria, using autoantibodies as diagnostic markers. This connection aids in classifying autoimmune urticaria subtypes. Management includes screening for thyroid involvement.
What treatments are used for chronic urticaria?
Omalizumab is effective for chronic spontaneous urticaria by blocking IgE. Antihistamines form first-line therapy, with biologics for refractory cases. Quality of life improves with these targeted approaches.
Open Research Questions
- ? How do autoantibodies specifically target mast cells in chronic spontaneous urticaria pathogenesis?
- ? What are the precise mechanisms linking thyroid autoimmunity to urticaria persistence?
- ? Which biomarkers beyond IgE best predict omalizumab response in urticaria patients?
- ? How do mast cell-nerve interactions contribute to cholinergic urticaria symptoms?
Recent Trends
The field holds steady at 64,745 papers with no specified 5-year growth rate.
High-citation works like "Mast cells" (Metcalfe et al. , 1701 citations) and "IgE, mast cells, basophils, and eosinophils" (Stone et al. (2010), 1627 citations) continue to anchor research on urticaria mechanisms.
1997No recent preprints or news coverage in the last 12 months indicates stable emphasis on established diagnostics and omalizumab management.
Research Urticaria and Related Conditions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Urticaria and Related Conditions with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers